Skip to main content

Table 1 Percent probe copy gains and losses for each histological category (CIN1 - n = 10; CIN2/3 - n = 10; SCC - n = 10)

From: Analysis of genetic copy number changes in cervical disease progression

  % of Samples with Probe Copy Gains   % of Samples with Probe Copy Loss
Probe CINa1 CINa2-3 SCCb Probe CINa1 CINa2-3 SCCb
8q24 0 80 100 3p14.2 20 20 80
3q26 30 80 100 2q33-q34 11 11 20
5p13 30 80 100 Xq11-q12 22 0 20
5p15.2 40 80 100 3p21-p23 11 0 18
CEPc8 30 78 100 Xp22.3 20 0 11
CEPcX 50 75 100 1q41 0 0 10
CEPc10 18 70 100 7p12.3-p12.1 0 0 10
CEPc16 20 60 100 CEPc7 10 0 10
CEPc12 10 56 100 2q23-q37 0 10 0
CEPc6 10 50 100 6q16.3-q21.3 0 10 0
CEPc9 0 44 100 6p21.2 10 10 0
CEPc11 20 44 100 8q24.12-24.13 0 0 0
CEPc1 13 43 100 CEPc16 0 0 0
CEPc17 10 40 100 20q13.2-q13.3 0 0 0
CEPc7 30 60 91 CEPc15 0 0 0
20q13.2-q13.3 10 80 90 2p24.1 0 0 0
CEPc15 0 70 90 CEPc18 0 0 0
2p24.1 20 67 90 11p15.5 0 0 0
1q41 9 60 90 11q13 0 0 0
7p12.3-p12.1 10 60 90 1p31.1.1 0 0 0
Xq11-q12 11 60 90 4p16.3 0 0 0
CEPc18 11 60 90 11q23 0 0 0
11q13 27 60 90 4p15.3 0 0 0
11p15.5 18 50 90 3q26 10 0 0
11p23 45 30 90 5p13 10 0 0
6q16.3-q21.3 10 40 82 5p15.2 10 0 0
6p21.2 0 10 82 CEPc8 10 0 0
Xp22.3 0 70 80 CEPcX 10 0 0
1p31.1.1 9 70 80 CEPc12 10 0 0
4p15.3 20 50 80 CEPc11 10 0 0
4p16.3 30 50 80 CEPc9 10 0 0
2q23-q37 20 30 80 CEPc17 10 0 0
3p21-p23 14 86 55 CEPc6 10 0 0
2q33-q34 33 44 50 CEPc1 13 0 0
3p14.2 10 60 9 CEPc10 18 0 0
  1. a = cervical intraepithelial neoplasia
  2. b = squamous cell carcinoma
  3. c = centromeric probe